Addus HomeCare (NASDAQ:ADUS - Get Free Report) is expected to be issuing its Q1 2025 quarterly earnings data after the market closes on Monday, May 5th. Analysts expect Addus HomeCare to post earnings of $1.33 per share and revenue of $341.66 million for the quarter.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $297.14 million during the quarter, compared to analysts' expectations of $291.04 million. On average, analysts expect Addus HomeCare to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Addus HomeCare Price Performance
Shares of Addus HomeCare stock traded up $1.08 during trading hours on Friday, hitting $105.00. 170,130 shares of the company's stock traded hands, compared to its average volume of 163,639. The company has a fifty day simple moving average of $97.46 and a 200-day simple moving average of $115.12. The stock has a market capitalization of $1.93 billion, a price-to-earnings ratio of 24.03, a PEG ratio of 1.41 and a beta of 0.85. Addus HomeCare has a 12-month low of $88.96 and a 12-month high of $136.72.
Analyst Ratings Changes
ADUS has been the subject of several research analyst reports. Macquarie restated an "outperform" rating and set a $129.00 price target on shares of Addus HomeCare in a research note on Thursday, February 27th. StockNews.com lowered Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Oppenheimer increased their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Stephens restated an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Tuesday, April 22nd. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $139.00.
View Our Latest Research Report on ADUS
About Addus HomeCare
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
